Form 4 for SGP SpyGlass Pharma, Inc.
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0002108044-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-11 | 2026-02-09 | SGP | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +20.0K | 25.4K | +367% | +$320.0K | |
| I | 2026-02-11 | 2026-02-09 | SGP | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +115.0K | 251.4K | +84% | +$1.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-09 | P | A | 20,000 | $16.00 | 25,450 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-09 | P | A | 115,000 | $16.00 | 251,427 | I See footnote | — | — | (F1) Shares held by New World Medical, Inc. (New World Medical). The Reporting Person is the Chief Executive Officer of New World Medical and as such has voting and investment control over the shares held by New World Medical. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest in the shares. |